• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of December 2

News
Video

Here are the top 5 biosimilar articles for the week of December 2, 2024.

Number 5: Regulatory policies influence the availability of affordable biosimilars, with varying impacts across different jurisdictions.

Number 4: The study findings demonstrate that the aflibercept biosimilar MYL-1701P is as effective and safe as the reference aflibercept in treating diabetic macular edema (DME), offering a promising option for reducing treatment costs and improving global access to care for patients with DME.

Number 3: The phase 3 trial (NCT04966338) found that a biosimilar ocrelizumab candidate (Xacrel) was equivalent to Ocrevus in reducing the annualized relapse rate and showed comparable safety and efficacy in treating relapsing multiple sclerosis over 96 weeks.

Number 2: Few biologics in the US have multiple biosimilar competitors, but originator biologics respond quickly to competition by increasing rebates and lowering net prices, despite short approval-to-launch timelines for biosimilars.

Number 1: Veterans with inflammatory bowel disease (IBD) prioritize shared decision-making, transparency, and individualized care in biosimilar switching, favoring delayed switching for severe cases and greater patient control.

To read all of these articles and more, visit centerforbiosimilars.com.

Recent Videos
Here are the top 5 biosimilar articles for the week of June 9, 2025.
Here are the top 5 biosimilar articles for the week of June 2, 2025.
Here are the top 5 biosimilar articles for the week of May 26, 2025.
Here are the top 5 biosimilar articles for the week of May 19, 2025.
Here are the top 5 biosimilar articles for the week of May 12, 2025.
Here are the top 5 biosimilar articles for the week of May 5, 2025.
Here are the top 5 biosimilar articles for the week of April 28, 2025.
Here are the top 5 biosimilar articles for the week of April 14, 2025.
Here are the top 5 biosimilar articles for the week of April 7, 2025.
Here are the top 5 biosimilar articles for the week of March 31, 2025.
© 2025 MJH Life Sciences

All rights reserved.